DOI: 10.12890/2026_007628
Central pontine myelinolysis in a patient undergoing isonatric haemodialysis: the potential role of metabolic and nutritional vulnerability
Authors
docteur.makarriel2017@gmail.com
Keywords
Central pontine myelinolysis, hypokalemia, isonatric haemodialysis, malnutrition, osmotic demyelination syndromeAbstract
Introduction: Central pontine myelinolysis (CPM) is usually associated with rapid correction of hyponatremia but may occur in normonatremic patients. Its occurrence during isonatric haemodialysis raises questions about metabolic vulnerability.
Case description: A 65-year-old man receiving maintenance haemodialysis since 2020, subsequently managed with an isonatric strategy, developed progressive tremors, dizziness, gait instability, falls, and cognitive impairment. Brain magnetic resonance imaging in August 2023 revealed a central pontine lesion suggestive of CPM, which was unchanged in April 2024. Previous imaging during an ischemic stroke in 2021 showed no pontine lesion. Predialysis sodium ranged from 138 to 143 mmol/l, without documented rapid correction. Recurrent postdialysis hypokalemia (minimum 3.1 mmol/l), hypoalbuminemia (23 g/l), low prealbumin (12 mg/dl), and inflammation (C-reactive protein 153.4 mg/l) were documented. In June 2024, propranolol, potassium supplementation, and intradialytic parenteral and oral nutritional support were initiated. In July, albumin reached 37.7 g/l, prealbumin 23.6 mg/dl, and C-reactive protein 4.9 mg/l. Treatment was well tolerated. Tremors improved, and the patient regained independence.
Discussion: Recurrent hypokalemia and nutritional and inflammatory abnormalities may increase susceptibility to osmotic demyelination despite limited sodium fluctuations. However, their causal contribution remains uncertain.
Conclusion: CPM should be considered in haemodialysis patients with progressive neurological symptoms, even without documented hyponatremia.
References
- Huang WY, Weng WC, Peng TI, Ro LS, Yang CW, Chen KH. Central pontine and extrapontine myelinolysis after rapid correction of hyponatremia by hemodialysis in a uremic patient. Ren Fail. 2007;29(5):635-638. doi: 10.1080/08860220701392314.
- Bastos AP, Rocha PN. Osmotic demyelination as a complication of hyponatremia correction: a systematic review. J Bras Nefrol. 2024;46(1):47-55. doi: 10.1590/2175-8239-JBN-2022-0114en.
- Ravioli S, Fussi F, Schwarz C, Lindner G. Non-hyponatremia-associated osmotic demyelination syndrome: an analysis of published cases. Am J Med. 2026;139(4):495-499. doi: 10.1016/j.amjmed.2025.12.030.
- Treves B, Consalvo F, Delogu G, Morena D, Padovano M, Santurro A, et al. Osmotic demyelination syndrome: revisiting the diagnostic criteria through two fatal cases. BMC Neurol. 2024;24:428. doi: 10.1186/s12883-024-03934-3.
- Annangi S, Nutalapati S, Naramala S, Yarra P, Bashir K. Uremia Preventing Osmotic Demyelination Syndrome Despite Rapid Hyponatremia Correction. J Investig Med High Impact Case Rep. 2020;8:2324709620918095. doi: 10.1177/2324709620918095.
- Sathiavageesan S. Fatal osmotic demyelination following urgent start of hemodialysis in a patient with normal serum sodium. Hemodial Int. 2025;29(1):121-125. doi: 10.1111/hdi.13184.
- Lohr JW. Osmotic demyelination syndrome following correction of hyponatremia: association with hypokalemia. Am J Med. 1994;96(5):408-413. doi: 10.1016/0002-9343(94)90166-x.
- Heng AE, Vacher P, Aublet-Cuvelier B, Garcier JM, Sapin V, Deteix P, et al. Centropontine myelinolysis after correction of hyponatremia: role of associated hypokalemia. Clin Nephrol. 2007;67(6):345-351. doi :10.5414/cnp67345.